Image

Early Postoperative Physiotherapy to Prevent Respiratory Insufficiency After Elective Heart Surgery

Early Postoperative Physiotherapy to Prevent Respiratory Insufficiency After Elective Heart Surgery

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

This study aims to determine whether starting respiratory physiotherapy one hour after removal of the breathing tube following elective coronary artery bypass graft (CABG) surgery leads to better recovery than the current standard approach, in which physiotherapy begins on the first postoperative day. The study will evaluate whether earlier physiotherapy improves lung function, reduces postoperative pulmonary complications, shortens intensive care unit and hospital stay, decreases pain and anxiety, and improves overall recovery after surgery. The main question is whether very early postoperative respiratory physiotherapy provides additional benefits for patients recovering from elective heart surgery compared with standard postoperative care.

Description

This study is designed to evaluate the effectiveness of early postoperative physiotherapy initiated one hour after extubation in patients undergoing elective coronary artery bypass graft (CABG) surgery. Postoperative pulmonary complications remain among the most frequent causes of morbidity following cardiac surgery and may contribute to prolonged intensive care unit and hospital stay, delayed functional recovery, and increased healthcare utilization. Early physiotherapy has been recognized as an important component of postoperative rehabilitation; however, the optimal timing for its initiation has not been clearly established. This study aims to investigate whether initiating physiotherapy one hour after extubation provides additional clinical benefits compared with the current standard practice of commencing physiotherapy on the first postoperative day. The protocol includes standardized perioperative management and physiotherapy procedures to ensure consistency of the intervention and outcome assessment. The study will be conducted at the University Hospital Centre Zagreb in accordance with the principles of Good Clinical Practice, the Declaration of Helsinki, and applicable ethical and regulatory requirements.

Eligibility

Inclusion Criteria:

  • Adults aged 18-80 years
  • Male and female participants
  • Elective coronary artery bypass grafting (CABG)
  • Body mass index (BMI) \< 30 kg/m²
  • Left ventricular ejection fraction (EF) \> 25%
  • Extubated on postoperative day 0 (POD 0)
  • Able and willing to provide written informed consent
  • Able to perform spirometry and follow study instructions

Exclusion Criteria:

  • Refusal or inability to provide informed consent
  • Emergency CABG surgery
  • Previous cardiac surgery
  • Severe cardiac arrhythmias (e.g., ventricular tachycardia/fibrillation, third-degree atrioventricular block)
  • Previous stroke
  • Motor impairment of upper or lower extremities due to neurological or musculoskeletal disease
  • Dyskinesia
  • Not extubated on POD 0
  • Significant postoperative neurological complications
  • Peripheral arterial disease of the lower extremities or previous lower-limb amputation
  • Acute or chronic pulmonary disease
  • Preoperative FEV1 \<30% of predicted (greater than 70% reduction)
  • Inability to perform spirometry correctly
  • Cancelled surgery after preoperative assessment
  • Extubation later than 24 hours after surgery
  • Requirement for continuous positive airway pressure (CPAP) after extubation SpO₂ \<90% one hour after extubation despite oxygen supplementation (4 L/min by nasal cannula)
  • Return to the operating room after the initial CABG procedure
  • Requirement for dialysis (acute or chronic)

Study details
    CABG
    Respiratory Insufficiency
    Postoperative Pulmonary Complications (PPCs)

NCT07730034

Dijana Filipović

15 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.